John C. Stivelman

1.5k total citations
16 papers, 1.1k citations indexed

About

John C. Stivelman is a scholar working on Nephrology, Hematology and Genetics. According to data from OpenAlex, John C. Stivelman has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Nephrology, 8 papers in Hematology and 4 papers in Genetics. Recurrent topics in John C. Stivelman's work include Dialysis and Renal Disease Management (9 papers), Iron Metabolism and Disorders (7 papers) and Erythropoietin and Anemia Treatment (5 papers). John C. Stivelman is often cited by papers focused on Dialysis and Renal Disease Management (9 papers), Iron Metabolism and Disorders (7 papers) and Erythropoietin and Anemia Treatment (5 papers). John C. Stivelman collaborates with scholars based in United States, Canada and Ireland. John C. Stivelman's co-authors include Jonathan Himmelfarb, James F. Winchester, Donal Reddan, Lynda A. Szczech, Daniel L. Gillen, Connie L. Davis, A. Mazhar, Michael J. Ryan, Richard J. Johnson and Catherine Stehman‐Breen and has published in prestigious journals such as Kidney International, Journal of the American Society of Nephrology and American Journal of Kidney Diseases.

In The Last Decade

John C. Stivelman

16 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John C. Stivelman United States	12	756	318	297	253	142	16	1.1k
Mehdi Rambod United States	17	735 1.0×	226 0.7×	131 0.4×	222 0.9×	67 0.5×	35	1.3k
Z. Arat Türkiye	21	457 0.6×	156 0.5×	143 0.5×	397 1.6×	40 0.3×	88	1.3k
Nuhad Ismail United States	7	526 0.7×	174 0.5×	100 0.3×	154 0.6×	77 0.5×	8	808
Tadashi Tomo Japan	17	964 1.3×	229 0.7×	126 0.4×	304 1.2×	77 0.5×	66	1.3k
J. Bömmer Germany	17	625 0.8×	220 0.7×	126 0.4×	211 0.8×	34 0.2×	60	1.1k
Paul A. Fein United States	20	1.1k 1.5×	290 0.9×	127 0.4×	337 1.3×	29 0.2×	38	1.5k
George A. Kaysen United States	9	771 1.0×	227 0.7×	116 0.4×	327 1.3×	27 0.2×	9	1.0k
Albert H.A. Mazairac Netherlands	18	883 1.2×	242 0.8×	95 0.3×	383 1.5×	101 0.7×	22	1.1k
W Fassbinder Germany	17	341 0.5×	116 0.4×	190 0.6×	210 0.8×	52 0.4×	72	1.0k
Soraya Abad Spain	17	495 0.7×	112 0.4×	158 0.5×	261 1.0×	30 0.2×	65	870

Countries citing papers authored by John C. Stivelman

Since Specialization

Citations

This map shows the geographic impact of John C. Stivelman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Stivelman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Stivelman more than expected).

Fields of papers citing papers by John C. Stivelman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John C. Stivelman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Stivelman. The network helps show where John C. Stivelman may publish in the future.

Co-authorship network of co-authors of John C. Stivelman

This figure shows the co-authorship network connecting the top 25 collaborators of John C. Stivelman. A scholar is included among the top collaborators of John C. Stivelman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John C. Stivelman. John C. Stivelman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Stivelman, John C.. (2017). Target‐based Anemia Management with Erythropoiesis Stimulating Agents (Risks and Benefits Relearned) and Iron (Still More to Learn). Seminars in Dialysis. 30(2). 142–148. 4 indexed citations

Stivelman, John C.. (2012). Monitoring Quality of Care at Dialysis Facilities. Clinical Journal of the American Society of Nephrology. 7(10). 1673–1681. 3 indexed citations

Inrig, Jula K., Uptal D. Patel, Robert D. Toto, et al.. (2009). Decreased pulse pressure during hemodialysis is associated with improved 6-month outcomes. Kidney International. 76(10). 1098–1107. 44 indexed citations

Inrig, Jula K., Uptal D. Patel, Barbara S. Gillespie, et al.. (2007). Relationship Between Interdialytic Weight Gain and Blood Pressure Among Prevalent Hemodialysis Patients. American Journal of Kidney Diseases. 50(1). 108–118.e4. 87 indexed citations

Inrig, Jula K., E.Z. Oddone, Vic Hasselblad, et al.. (2007). Association of intradialytic blood pressure changes with hospitalization and mortality rates in prevalent ESRD patients. Kidney International. 71(5). 454–461. 159 indexed citations

Dittrich, Mary, et al.. (2006). Transdermal Androgen Therapy to Augment EPO in the Treatment of Anemia of Chronic Renal Disease. American Journal of Kidney Diseases. 47(2). 251–262. 62 indexed citations

Reddan, Donal, Lynda A. Szczech, Vic Hasselblad, et al.. (2005). Intradialytic Blood Volume Monitoring in Ambulatory Hemodialysis Patients. Journal of the American Society of Nephrology. 16(7). 2162–2169. 151 indexed citations

Mazhar, A., Richard J. Johnson, Daniel L. Gillen, et al.. (2001). Risk factors and mortality associated with calciphylaxis in end-stage renal disease. Kidney International. 60(1). 324–332. 259 indexed citations

Stivelman, John C.. (2000). Benefits of anaemia treatment on cognitive function. Nephrology Dialysis Transplantation. 15(suppl_3). 29–35. 69 indexed citations

10.

Parker, Kathryn, William E. Mitch, John C. Stivelman, et al.. (1997). Safety and efficacy of low-dose subcutaneous erythropoietin in hemodialysis patients.. Journal of the American Society of Nephrology. 8(2). 288–293. 30 indexed citations

11.

Stivelman, John C.. (1996). Injectable Medications for Hemodialysis Patients. American Journal of Nephrology. 16(1). 73–78. 2 indexed citations

12.

Stivelman, John C., J. Michael Soucie, Eric S. Hall, & Edwin J. Macon. (1995). Dialysis survival in a large inner-city facility. Journal of the American Society of Nephrology. 6(4). 1256–1261. 12 indexed citations

13.

Stivelman, John C.. (1994). Optimization of Iron Therapy in Hemodialysis Patients Treated with rHuEPO. Seminars in Dialysis. 7(4). 288–292. 7 indexed citations

14.

Wyck, David B. Van, et al.. (1989). Iron status in patients receiving erythropoietin for dialysis-associated anemia. Kidney International. 35(2). 712–716. 171 indexed citations

15.

Stivelman, John C., Gerald Schulman, Martin Fosburg, J. Michael Lazarus, & Raymond M. Hakim. (1989). Kinetics and efficacy of deferoxamine in iron-overloaded hemodialysis patients. Kidney International. 36(6). 1125–1132. 18 indexed citations

16.

Stivelman, John C., Gerald Schulman, Martin Fosburg, et al.. (1987). Iron Overload and Mobilization in Long-Term Hemodialysis Patients. American Journal of Kidney Diseases. 10(4). 293–299. 44 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact